Pillar Pharmaceuticals 6, L.P. (CIK: 0001783584) EDGAR, Information, Filings... CompaniesBIO.Com

Pillar Pharmaceuticals 6, L.P.

Mailing address
STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAUOK STREET, BEIRUT, Cayman Islands, 2020-3313
Phone
961 1 363 362
State location
Lebanon
State of incorporation
Cayman Islands
Fiscal year end
December 31
SIC
N/A
Filings
N/A

Pillar Pharmaceuticals 6, L.P. (CIK: 0001783584) is an American company incorporated in the state of Lebanon. Head office is located at STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAUOK STREET, BEIRUT, Lebanon, 2020-3313. Work in the industry N/A. Pillar Pharmaceuticals 6, L.P. is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Pillar Pharmaceuticals 6, L.P.

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-23-202969 ( Act) Size: 129 KB	Aug-03-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-23-017446 (34 Act) Size: 14 KB	Jul-19-2023	001-31918 231096740
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-23-017445 (34 Act) Size: 16 KB	Jul-19-2023	001-31918 231096732
3/A	Document	Amendment to Initial statement of beneficial ownership of securities Acc-no: 0000899243-23-017444 (34 Act) Size: 17 KB	Jul-19-2023	001-31918 231096727
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-23-187666 ( Act) Size: 112 KB	Jul-17-2023
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0000899243-23-016434 (34 Act) Size: 17 KB	Jun-23-2023	001-31918 231039139
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-23-096589 ( Act) Size: 104 KB	Apr-10-2023
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-23-019124 ( Act) Size: 110 KB	Jan-30-2023
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-22-258236 ( Act) Size: 122 KB	Oct-05-2022
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-22-032038 (34 Act) Size: 17 KB	Sep-26-2022	001-31918 221266110
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-22-186355 ( Act) Size: 103 KB	Jul-01-2022
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-22-181610 ( Act) Size: 125 KB	Jun-24-2022
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-21-184508 ( Act) Size: 144 KB	Jun-07-2021
4/A	Document	Amendment to Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-017527 (34 Act) Size: 21 KB	Apr-29-2021	001-31918 21873483
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-21-102816 ( Act) Size: 154 KB	Apr-01-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-21-014303 (34 Act) Size: 30 KB	Mar-31-2021	001-31918 21795797
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-20-329317 ( Act) Size: 154 KB	Dec-30-2020
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-20-033917 (34 Act) Size: 27 KB	Dec-15-2020	001-31918 201390670
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-20-024396 (34 Act) Size: 20 KB	Sep-04-2020	001-31918 201162713
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-20-005917 (34 Act) Size: 24 KB	Feb-26-2020	001-31918 20657045

Recent 20 filings. View all Pillar Pharmaceuticals 6, L.P. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Pillar Pharmaceuticals 6, L.P. overview
Pillar Pharmaceuticals 6, L.P. job
Pillar Pharmaceuticals 6, L.P. stock
Pillar Pharmaceuticals 6, L.P. ownership
Pillar Pharmaceuticals 6, L.P. CEO
Pillar Pharmaceuticals 6, L.P. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.